<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmacogenetics | Drögemöller Lab</title>
    <link>/tag/pharmacogenetics/</link>
      <atom:link href="/tag/pharmacogenetics/index.xml" rel="self" type="application/rss+xml" />
    <description>Pharmacogenetics</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 01 Feb 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>Pharmacogenetics</title>
      <link>/tag/pharmacogenetics/</link>
    </image>
    
    <item>
      <title>CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines</title>
      <link>/publication/drogemoller-cyp-2-d-6-2019/</link>
      <pubDate>Fri, 01 Feb 2019 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-cyp-2-d-6-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients</title>
      <link>/publication/zazuli-outcome-2019/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/zazuli-outcome-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research</title>
      <link>/publication/drogemoller-pharmacogenomics-2019/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-pharmacogenomics-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</title>
      <link>/publication/wright-pharmacogenomics-2019/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/wright-pharmacogenomics-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer</title>
      <link>/publication/drogemoller-association-2017/</link>
      <pubDate>Wed, 01 Nov 2017 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-association-2017/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Considerations for rare variants in drug metabolism genes and the clinical implications</title>
      <link>/publication/drogemoller-considerations-2014/</link>
      <pubDate>Sun, 01 Jun 2014 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-considerations-2014/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment</title>
      <link>/publication/drogemoller-next-generation-2013/</link>
      <pubDate>Sun, 01 Dec 2013 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-next-generation-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characterization of the genetic variation present in CYP3A4 in three South African populations</title>
      <link>/publication/drogemoller-characterization-2013/</link>
      <pubDate>Tue, 01 Jan 2013 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-characterization-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications</title>
      <link>/publication/drogemoller-whole-genome-2011/</link>
      <pubDate>Thu, 01 Dec 2011 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-whole-genome-2011/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Psychiatric genetics in South Africa: cutting a rough diamond</title>
      <link>/publication/wright-psychiatric-2011/</link>
      <pubDate>Tue, 01 Nov 2011 00:00:00 +0000</pubDate>
      <guid>/publication/wright-psychiatric-2011/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characterization of the genetic profile of CYP2C19 in two South African populations</title>
      <link>/publication/drogemoller-characterization-2010/</link>
      <pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-characterization-2010/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population</title>
      <link>/publication/wright-elucidation-2010/</link>
      <pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate>
      <guid>/publication/wright-elucidation-2010/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
